SWTX - SpringWorks Therapeutics, Inc.
46.99
0.010 0.021%
Share volume: 5,010,844
Last Updated: 06-30-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$46.98
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-02-2024 | 08-07-2024 | 11-12-2024 | 02-20-2025 | 05-09-2025 | |
| Total revenue | 21.006 M | 59.733 M | 49.301 M | 61.549 M | 49.087 M | |
| Cost of revenue | 1.202 M | 2.453 M | 3.341 M | 5.554 M | 3.527 M | |
| Gross profit | 19.804 M | 57.280 M | 45.960 M | 55.995 M | 45.560 M | |
| 189.23% | -19.76% | 21.83% | -18.64% | |||
| Operating expenses | 113.735 M | 102.201 M | 103.897 M | 137.337 M | 126.096 M | |
| Selling general and admin | 60.113 M | 57.839 M | 61.601 M | 77.099 M | 76.501 M | |
| Research and development | 53.622 M | 44.362 M | 42.296 M | 60.238 M | 49.595 M | |
| Total expenses | 113.735 M | 102.201 M | 103.897 M | 137.337 M | 126.096 M | |
| -10.14% | 1.66% | 32.19% | -8.18% | |||
| Operating income | -93.931 M | -44.921 M | -57.937 M | -81.342 M | -80.536 M | |
| Ebit | -93.931 M | -44.921 M | -57.937 M | -81.342 M | -80.536 M | |
| Pretax income | -86.360 M | -38.143 M | -51.721 M | -75.907 M | -81.534 M | |
| -55.83% | 35.60% | 46.76% | 7.41% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -87.385 M | -39.919 M | -53.530 M | -77.297 M | -83.187 M | |
| 54.32% | -34.10% | -44.40% | -7.62% |